Ultimately the goal of Winn CDA is to improve health equity by improving healthcare for underserved and vulnerable people. This program will tackle the challenge by: working within communities; establishing a career development program to support Early-Stage Investigators (ESI) URiM, or those with a demonstrated commitment to diversity in clinical trials; and building a pathway of diverse healthcare workers (through an investment in diverse medical students). All of these aims will help increase the number of underrepresented patients who participate in clinical trials. More participation by underrepresented groups in clinical trials will help healthcare providers to better treat the diseases that impact them.